"10.1371_journal.pone.0051302","plos one","2012-12-10T00:00:00Z","Rasmus Ribel-Madsen; Mario F Fraga; Stine Jacobsen; Jette Bork-Jensen; Ester Lara; Vincenzo Calvanese; Agustin F Fernandez; Martin Friedrichsen; Birgitte F Vind; Kurt Højlund; Henning Beck-Nielsen; Manel Esteller; Allan Vaag; Pernille Poulsen","Steno Diabetes Center, Gentofte, Denmark; Section of Metabolic Genetics, The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain; Department of Cancer Epigenetics, Spanish National Cancer Research Centre, Madrid, Spain; Cancer Epigenetics Laboratory, Instituto Universitario de Oncologia del Principado de Asturias, HUCA, Universidad de Oviedo, Oviedo, Spain; Department of Endocrinology, Odense University Hospital, Odense, Denmark; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark; Novo Nordisk A/S, Søborg, Denmark","Conceived and designed the experiments: PP MFF AV KH HB-N. Performed the experiments: RR-M AFF MFF EL VC SJ BFV PP AV. Analyzed the data: RR-M JB-J AFF MF. Contributed reagents/materials/analysis tools: MFF AFF ME. Wrote the paper: RR-M PP AV.","RR-M MFF, SJ, JB-J, EL, VC, AFF, MF, BFV, KH, HB-N, ME and AV have declared that no competing interests exist. The authors have read the journal's policy and have the following financial conflict: PP is employed in Novo Nordisk A/S. There are no patents, products in development or marketed products to declare. This does not alter the authors‚ adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Rasmus Ribel-Madsen","RRM",14,FALSE,5,9,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
